Products
-
- BBB DamageCell Death and ApoptosisNeuroinflammationNeuronal Damage and RepairOxidative StressVascular Mechanisms
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Recombinant Human Ninjurin 1 Protein (Fc Tag) (AC1012)
Cat.#: ACPP-1012
Specifications
Despition Recombinant Human Ninjurin 1 Protein (Fc Tag) for SDS-PAGE SIZE 50 µg Source Recombinant Protein Length Fragment Expression System HEK293 cells Protein Species Human Sequence NINJ1 (Met1-Leu80) + hFc (Glu99-Ala330) Molecular Weight 34.6 kDa without signal peptide Purity > 95% by SDS-PAGE and Coomassie blue staining. Form Lyophilized Tag C-terminal Human Fc Tag Applications SDS-PAGE Storage Lyophilized was stored at -20°C to -80°C, while reconstituted was aliquot and stored at -80°C. Avoid freeze/thaw cycles. Shipping Shipped at 4°C Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Size Price ACPP-1250 Lin28 Blocking Peptide (AC1250) 250 µg inquiry ACPP-1403 Human Insulin (Active) Protein (AC1403) 1 mg inquiry ACPP-1732 Human CHRNA6 Protein (AC1732) 5 µg inquiry ACPP-1096 Synthetic Nanodisc Human CXCR4 Protein (AC1096) 10 µg inquiry ACPP-1153 MERTK Blocking Peptide (AC1153) 250 µg inquiry ACPP-1207 Dopamine Receptor D1 Blocking Peptide (AC1207) 250 µg inquiry ACPP-1290 Insulin Receptor Blocking Peptide (AC1290) 250 µg inquiry ACPP-1834 Human BAALC Protein (AC1834) 2 µg inquiry ACPP-1053 Recombinant Mouse CD24 Protein (Fc Tag) (AC1053) 50 µg inquiry ACPP-1409 Human TULP1 Protein (AC1409) 5 µg inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
0Inquiry Basket